State
72,984 recalls have nationwide distribution and so reach Northern Mariana Islands. 22 additional recalls listed Northern Mariana Islands specifically in their distribution scope.
Of the 22 recalls naming Northern Mariana Islands we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 8 (36%) are Severe.
Which agencies issued them
These figures cover only the 22 recalls whose distribution notice names Northern Mariana Islands specifically. The 72,984 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Glenmark Pharmaceuticals is voluntarily recalling Indomethacin Extended-Release Capsules (75mg) distributed nationwide due to Good Manufacturing Practice deviations identified during FDA oversight.
Glenmark Pharmaceuticals is recalling Lacosamide 100mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The firm initiated this voluntary recall on March 13, 2025.
Glenmark Pharmaceuticals is recalling Propafenone Hydrochloride Extended-Release Capsules 225mg (Lot #17230819) nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall is voluntary and initiated by the manufacturer.
Glenmark Pharmaceuticals Inc., USA is recalling Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mg nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall is voluntary and initiated by the firm.
Glenmark Pharmaceuticals is recalling Lacosamide Tablets 200mg nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall is voluntary and affects specific lot numbers with expiration dates ranging from April 2025 to April 2026.
Glenmark Pharmaceuticals is recalling Rufinamide 200mg tablets nationwide due to manufacturing process deviations. The voluntary recall affects certain lot numbers with July 2025 expiration dates.
Glenmark Pharmaceuticals is recalling Saxagliptin 2.5mg tablets nationwide due to manufacturing quality issues. The firm initiated this voluntary recall on March 13, 2025.
Glenmark Pharmaceuticals Inc., USA is recalling Frovatriptan Succinate 2.5mg tablets nationwide due to current Good Manufacturing Practice (CGMP) deviations. The FDA has classified this as a Class II recall.
Glenmark Pharmaceuticals Inc., USA is recalling Nitroglycerin Sublingual Tablets 0.4 MG due to Current Good Manufacturing Practice (CGMP) deviations. The recall affects specific lot numbers distributed nationwide.
Glenmark Pharmaceuticals Inc., USA is voluntarily recalling Carvedilol Tablets, USP 12.5 mg due to CGMP (Current Good Manufacturing Practice) deviations. The recall affects specific lots distributed nationwide.
Glenmark Pharmaceuticals Inc. is voluntarily recalling Gabapentin 600mg tablets (500-count bottles) nationwide due to Current Good Manufacturing Practice (CGMP) deviations identified during manufacturing.
Glenmark Pharmaceuticals Inc., USA is recalling Solifenacin Succinate 5mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The recall is voluntary and affects 30-count and 90-count bottles distributed across the U.S.
Sun Pharmaceutical Industries is recalling Gabapentin Capsules, USP 300 mg, due to cross contamination. The recall affects approximately 12,876 bottles distributed nationwide.
Sun Pharmaceutical Industries Inc. is recalling Gabapentin Capsules 400 mg due to cross contamination. The recall affects 852 bottles distributed nationwide.
Audi is recalling 2022-2023 RS E-TRON GT and E-TRON GT vehicles because a wiring fault may deactivate the front passenger air bag, increasing injury risk in a crash.
Chrysler is recalling certain 2023-2025 Alfa Romeo Tonale and Dodge Hornet vehicles because the display module may not show the rearview camera image, failing FMVSS 111.
Goodyear is recalling specific Cooper Discoverer Stronghold AT tires because they lack the required week and year code. This prevents owners from determining the tire's age or recall status.
Prevost is recalling 2025 H3-45 and X3-45 motorcoaches because emergency exit windows may be difficult to open, increasing injury risk.
Nova Bus is recalling specific ZF brake chambers sold as replacement parts for buses because improper manufacturing may cause air leaks, increasing the risk of unexpected braking, overheating, or fire.
Oshkosh is recalling 216 model-year 2025 NGDV vehicles because the rearview camera image may not display in reverse, increasing crash risk.
Maserati is recalling 2024 Granturismo vehicles because the tire label may detach, potentially leading to vehicle overload and increased crash risk.
Forest River is recalling certain 2024-2025 trailers with a removable step assembly because the clip-on bracket mounting bolt may allow the steps to detach in use.
Ford is recalling 2017-2018 F-150, Expedition, and Lincoln Navigator vehicles because a brake master cylinder defect may cause fluid leaks, reducing braking ability and increasing crash risk.
Ford is recalling 2024-2025 E-Transit Chassis vehicles because battery tray rails may crack, allowing water entry that could cause a fire.
Mercedes-Benz is recalling 2024 E 350 and E 450 vehicles because improperly secured electrical ground connections may overheat and increase the risk of a fire.